» Articles » PMID: 38607067

Generation of Artificial Blastoids Combining MiR-200-Mediated Reprogramming and Mechanical Cues

Overview
Journal Cells
Publisher MDPI
Date 2024 Apr 12
PMID 38607067
Authors
Affiliations
Soon will be listed here.
Abstract

In vitro-generated blastocyst-like structures are of great importance since they recapitulate specific features or processes of early embryogenesis, thus avoiding ethical concerns as well as increasing scalability and accessibility compared to the use of natural embryos. Here, we combine cell reprogramming and mechanical stimuli to create 3D spherical aggregates that are phenotypically similar to those of natural embryos. Specifically, dermal fibroblasts are reprogrammed, exploiting the miR-200 family property to induce a high plasticity state in somatic cells. Subsequently, miR-200-reprogrammed cells are either driven towards the trophectoderm (TR) lineage using an ad hoc induction protocol or encapsulated into polytetrafluoroethylene micro-bioreactors to maintain and promote pluripotency, generating inner cell mass (ICM)-like spheroids. The obtained TR-like cells and ICM-like spheroids are then co-cultured in the same micro-bioreactor and, subsequently, transferred to microwells to encourage blastoid formation. Notably, the above protocol was applied to fibroblasts obtained from young as well as aged donors, with results that highlighted miR-200's ability to successfully reprogram young and aged cells with comparable blastoid rates, regardless of the donor's cell age. Overall, the approach here described represents a novel strategy for the creation of artificial blastoids to be used in the field of assisted reproduction technologies for the study of peri- and early post-implantation mechanisms.

Citing Articles

In Vitro Models of Cardiovascular Disease: Embryoid Bodies, Organoids and Everything in Between.

Stougiannou T, Christodoulou K, Karangelis D Biomedicines. 2025; 12(12.

PMID: 39767621 PMC: 11726960. DOI: 10.3390/biomedicines12122714.


Bioengineering-tissue strategies to model mammalian implantation .

Pennarossa G, Arcuri S, Zmijewska A, Orini E, Gandolfi F, Brevini T Front Bioeng Biotechnol. 2024; 12:1430235.

PMID: 39132254 PMC: 11310004. DOI: 10.3389/fbioe.2024.1430235.

References
1.
Pennarossa G, Arcuri S, De Iorio T, Ledda S, Gandolfi F, Brevini T . Combination of epigenetic erasing and mechanical cues to generate human epiBlastoids from adult dermal fibroblasts. J Assist Reprod Genet. 2023; 40(5):1015-1027. PMC: 10024007. DOI: 10.1007/s10815-023-02773-4. View

2.
Luijkx D, Shankar V, van Blitterswijk C, Giselbrecht S, Vrij E . From Mice to Men: Generation of Human Blastocyst-Like Structures . Front Cell Dev Biol. 2022; 10:838356. PMC: 8963787. DOI: 10.3389/fcell.2022.838356. View

3.
Mazid M, Ward C, Luo Z, Liu C, Li Y, Lai Y . Rolling back human pluripotent stem cells to an eight-cell embryo-like stage. Nature. 2022; 605(7909):315-324. DOI: 10.1038/s41586-022-04625-0. View

4.
Yanagida A, Spindlow D, Nichols J, Dattani A, Smith A, Guo G . Naive stem cell blastocyst model captures human embryo lineage segregation. Cell Stem Cell. 2021; 28(6):1016-1022.e4. PMC: 8189436. DOI: 10.1016/j.stem.2021.04.031. View

5.
Brevini T, Pennarossa G, Attanasio L, Vanelli A, Gasparrini B, Gandolfi F . Culture conditions and signalling networks promoting the establishment of cell lines from parthenogenetic and biparental pig embryos. Stem Cell Rev Rep. 2010; 6(3):484-95. DOI: 10.1007/s12015-010-9153-2. View